These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23857437)

  • 1. Role of fibrinogen in massive injury.
    Maung AA; Kaplan LJ
    Minerva Anestesiol; 2014 Jan; 80(1):89-95. PubMed ID: 23857437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy.
    Brenni M; Worn M; Brüesch M; Spahn DR; Ganter MT
    Acta Anaesthesiol Scand; 2010 Jan; 54(1):111-7. PubMed ID: 19860752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severely injured trauma patients with admission hyperfibrinolysis: Is there a role of tranexamic acid? Findings from the PROPPR trial.
    Khan M; Jehan F; Bulger EM; OʼKeeffe T; Holcomb JB; Wade CE; Schreiber MA; Joseph B;
    J Trauma Acute Care Surg; 2018 Nov; 85(5):851-857. PubMed ID: 29985230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging treatment strategies for trauma-induced coagulopathy.
    Sorensen B; Fries D
    Br J Surg; 2012 Jan; 99 Suppl 1():40-50. PubMed ID: 22441854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperfibrinolysis as the cause of haemorrhage and increased mortality in trauma patients].
    Wikkelsø AJ; Afshari A; Stensballe J; Johansson PI
    Ugeskr Laeger; 2011 May; 173(18):1284-7. PubMed ID: 21535978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid, fibrinogen concentrate, and prothrombin complex concentrate: data to support prehospital use?
    Schöchl H; Schlimp CJ; Maegele M
    Shock; 2014 May; 41 Suppl 1():44-6. PubMed ID: 24296431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of therapeutic strategies for bleeding injury on early survival, transfusion needs and correction of coagulopathy.
    Balvers K; van Dieren S; Baksaas-Aasen K; Gaarder C; Brohi K; Eaglestone S; Stanworth S; Johansson PI; Ostrowski SR; Stensballe J; Maegele M; Goslings JC; Juffermans NP;
    Br J Surg; 2017 Feb; 104(3):222-229. PubMed ID: 28079258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of tranexamic acid and prothrombin complex concentrate on the coagulopathy of trauma: an in vitro analysis of the impact of severe acidosis.
    Porta CR; Nelson D; McVay D; Salgar S; Eckert M; Izenberg S; Martin MJ
    J Trauma Acute Care Surg; 2013 Dec; 75(6):954-60. PubMed ID: 24256666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolysis and antifibrinolytic treatment in the trauma patient.
    Gall LS; Davenport RA
    Curr Opin Anaesthesiol; 2018 Apr; 31(2):227-233. PubMed ID: 29324486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Massive transfusion and nonsurgical hemostatic agents.
    Perkins JG; Cap AP; Weiss BM; Reid TJ; Bolan CD
    Crit Care Med; 2008 Jul; 36(7 Suppl):S325-39. PubMed ID: 18594260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic defects in massive transfusion: an update and treatment recommendations.
    Napolitano LM
    Expert Rev Hematol; 2021 Feb; 14(2):219-239. PubMed ID: 33267678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.
    He S; Johnsson H; Zabczyk M; Hultenby K; Wallén H; Blombäck M
    Thromb Haemost; 2014 Mar; 111(3):417-28. PubMed ID: 24196490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolysis and tranexamic acid: mechanistic principles.
    Draxler DF; Medcalf RL
    ANZ J Surg; 2020 Apr; 90(4):410-411. PubMed ID: 32339417
    [No Abstract]   [Full Text] [Related]  

  • 14. The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding.
    Fries D
    Transfusion; 2013 Jan; 53 Suppl 1():91S-95S. PubMed ID: 23301979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massive transfusion and trauma patient management: pathophysiological approach to treatment.
    Zunini-Fernandez G; Rando-Huluk K; Martínez-Pelayo FJ; Castillo-Trevizo AL
    Cir Cir; 2011; 79(5):473-80. PubMed ID: 22385770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding.
    Levy JH; Szlam F; Tanaka KA; Sniecienski RM
    Anesth Analg; 2012 Feb; 114(2):261-74. PubMed ID: 21965371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trauma-induced coagulopathy.
    Godier A; Susen S
    Ann Fr Anesth Reanim; 2013; 32(7-8):527-30. PubMed ID: 23916515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of trauma-induced coagulopathy - what is the evidence?].
    Guth MC; Kaufner L; Kleber C; von Heymann C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2012 Sep; 47(9):528-39; quiz 540. PubMed ID: 22968981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma transfusion for patients with severe hemorrhage: what is the evidence?
    Callum JL; Rizoli S
    Transfusion; 2012 May; 52 Suppl 1():30S-7S. PubMed ID: 22578369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood transfusion and adjunctive therapy in the bleeding trauma patient].
    Ozier Y
    Transfus Clin Biol; 2008 Nov; 15(5):240-5. PubMed ID: 18930423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.